An observational study in Pathogen Resistance, sponsored by Hillel Yaffe Medical Center. Status unknown at 1 site in Israel. Open to participants aged Up to 3 Months. Per ClinicalTrials.gov, last updated 2017-03-10.
Sponsored by Hillel Yaffe Medical Center · Observational
To aim of this study is to identify the pathogens and their distribution in the NICU and to determine whether empirical antibiotics are suitable for the treatment of sepsis in the unit.
Hillel Yaffe Medical Center is the lead sponsor of 301 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Newborns hospitalized in NICU with positive cultures
Exclusion Criteria:
-
Positive cultures of newborns hospitalized in the NICU in the past 5 years will undergo laboratory examination and identification
Other: Laboratory identification of positive cultures
Laboratory identification of positive cultures
Antibiogram
Positive cultures will be examined using an antibiogram and pathogens will be identified
Time frame: One year
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hillel Yaffe Medical Center